FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved the original abbreviated new drug application for pantoprazole sodium from Rising Pharma Holdings, enabling the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Nsaid-associated Ulcer
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole sodium (pantoprazole sodium)

Snippet

ORIG AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)